Across TCGA pan-cancer cohorts, SNORA70J RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated SNORA70J data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SNORA70J RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORA70J expression acts as an unfavorable survival marker, although some lineages such as CESC and READ show a favorable association.
KIRP, KIRC, and MESO are the cancer types where SNORA70J RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.